Suppliers / Pierre Fabre Pharmaceuticals

Pierre Fabre Pharmaceuticals

France Updated 9 July 2026

Pierre Fabre Pharmaceuticals is a finished-dose manufacturer based in France. It appears in 90 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with SWISSMEDIC (CH), AIFA (IT) and EMA. Its GMP standing is certified by ZLG (DE) and EMA.

0
active US DMFs
0
valid CEPs
6
registered plants 1 with an FDA FEI number
90
filings across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Palezieux, Switzerland Not on file
Basel, Switzerland Not on file
Freiburg Im Breisgau, Germany Not on file
Baden-Wuerttemberg, Germany Not on file
Freiburg, Germany Not on file
Aurora, United States 3038219610

Filings and GMP by regulator

Regulator Filings GMP certificates
SWISSMEDIC (CH) 68 None
AIFA (IT) 14 None
EMA 8 3
ZLG (DE) None 8

Comparing suppliers?

Choose your molecules and target markets. Pierre Fabre Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates